- Supported exchanges /
- F /
- 96X.F
FLUOGUIDE A/S DK -1 (96X F) stock market data APIs
FluoGuide A/S, a clinical stage biotechnology company, focused on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; collaboration with Copenhagen University Hospital; collaboration with Intuitive Surgical, Inc. for robotics surgery in head and neck cancer. FluoGuide A/S was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
FLUOGUIDE A/S DK -1 Financial Data Overview
| 2.92 | |
| 2.89 | |
| - | |
| 2.92 | |
| 2.89 | |
| 2.89-9.88 | |
| 40 268 K | |
| 12 410 K | |
| 1 224 K | |
| 1.08 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
FLUOGUIDE A/S DK -1 Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 224 K
- EBITDA -40 014 000
- Earnings Per Share -0.4
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get FLUOGUIDE A/S DK -1 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get FLUOGUIDE A/S DK -1 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
